PRINCIPAL SECURITIES, INC.

Broker-Dealer

Position in RPRX — Royalty Pharma plc

CIK 12600 DES MOINES, IA

Position in RPRX

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$1,994,634

+$322,160 QoQ

Shares Held

35,574

+2.0% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#264

of 641 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

PRINCIPAL SECURITIES, INC. holds $9,913,561 across 11 Biotechnology names. RPRX ranks #2 (20.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	5,982	$2,971,438
2	RPRX	Royalty Pharma plc This page	35,574	$1,994,634
3	ARGX	Argenx SE	1,295	$1,201,462
4	INSM	INSMED Inc	6,728	$717,339
5	REGN	Regeneron Pharmaceuticals, Inc.	1,028	$640,999
6	EXEL	Exelixis, Inc.	11,237	$611,405
7	CORT	Corcept Therapeutics Inc	5,720	$497,354
8	ALNY	Alnylam Pharmaceuticals, Inc.	1,389	$418,130

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,994,634	35,574	+2.0%	Shares	Sole	2026-08-04
2026-03-31	$1,672,474	34,865	+15.3%	Shares	Sole	2026-05-13
2025-12-31	$1,168,087	30,230	+15.7%	Shares	Sole	2026-02-12
2025-09-30	$922,007	26,134	+9438.0%	Shares	Sole	2025-11-12
2025-06-30	$9,872	274	+47.3%	Shares	Sole	2025-08-11
2025-03-31	$5,790	186	0.0%	Shares	Sole	2025-04-30
2024-12-31	$4,744	186	+295.7%	Shares	Sole	2025-01-30
2024-09-30	$1,329	47	-2.1%	Shares	Sole	2024-10-28
2024-06-30	$1,265	48	+433.3%	Shares	Sole	2024-07-31
2024-03-31	$273	9	-69.0%	Shares	Sole	2024-05-10
2023-12-31	$814	29	—	Shares	Sole	2024-05-10
No filing history on record for this holder in this stock.